发明名称 COMPOSTO, COMPOSTO OU SAL DO MESMO, COMPOSIÇÃO FARMACÊUTICA, MODULADOR DE RECEPTOR DE GLICOCORTICÓIDE, MÉTODO PARA PREVENÇÃO E/OU TRATAMENTO DE BISTÚRBIOS METABÓLICOS, DOENÇAS INFLAMATÓRIAS, DOENÇAS AUTO-IMUNES, DOENÇAS ALÉRGICAS, DOENÇAS DO SISTEMA NERVOSO CENTRAL, DOENÇAS CARDIOVASCULARES, DOENÇAS RELACIONADAS COM HOMEOSTASE OU GLAUCOMA, E USO DE PELO MENOS UM COMPOSTO OU UM SAL DO MESMO
摘要 The compounds represented in general formula (1) or a salt thereof are useful for glucocorticoid receptor modulators. In the formula, R 1 represents a lower alkyl group, a lower cycloalkyl group, an aryl group and the like; R 2 represents a hydrogen atom, a lower alkyl group and the like; R 3 represents a hydrogen atom, a lower alkyl group and the like; R 4 and R 5 represent a hydrogen atom, a lower alkyl group and the like; R 6 represents a hydrogen atom, a lower alkyl group and the like; R 7 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group and the like; W represents an oxygen atom, a sulfur atom, NR 8 and the like; R 8 represents a hydrogen atom, a lower alkyl group and the like; X represents an oxygen atom or a sulfur atom; Y represents a lower alkylene group and the like; Z represents an oxygen atom, a sulfur atom, NR 9 , OCO or OSO 2 ; R 9 represents a hydrogen atom, a lower alkyl group and the like respectively.
申请公布号 BRPI0811262(A2) 申请公布日期 2014.11.04
申请号 BR2008PI11262 申请日期 2008.05.29
申请人 SANTEN PHARMACEUTICAL CO., LTD. 发明人 MAMORU MATSUDA;TOSHIYUKI MORI;MASATO NAGATSUKA;SACHIKO KOBAYASHI;MASATOMO KATO;MIWA TAKAI
分类号 C07D241/44;A61K31/498;A61P1/04;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P3/14;A61P5/50;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P17/02;A61P25/00;A61P25/18;A61P25/28;A61P27/06;A61P29/00;A61P37/00;A61P37/08;A61P43/00;C07D405/12;C07D409/12 主分类号 C07D241/44
代理机构 代理人
主权项
地址